Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Bioanalysis
|
January 24, 2017
An ultra-sensitive LC-MS/MS method to determine midazolam levels in human plasma: development, validation and application to a clinical study
Mu Chen, Wenzhe Lu, Yang Lu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 13, 2019
Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine
Jeroen Roosendaal, Kai Wang, Hilde Rosing, et al.
Bioanalysis
|
November 24, 2012
Bioanalysis of drug in tissue: current status and challenges
Y-J Xue, Hong Gao, Qin C Ji, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 26, 2013
A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography-tandem mass spectrometry
Weisheng Lin, Mike-Qingtao Huang, Xiaohua Xue, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 14, 2014
Quantitative analyses of CTP-499 and five major metabolites by core-structure analysis
Xiaonan Tang, Gary Bridson, Jing Ke, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
May 1, 2012
Pilot and pivotal study to evaluate the bioequivalence of two paroxetine 40 mg tablet formulations in healthy Chinese subjects
Shengjun Zhang, Quancheng Kan, Jian Guo Wen, et al.
Bioanalysis
|
June 18, 2011
Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis
Steve Lowes, Jim Jersey, Ronald Shoup, et al.
Bioanalysis
|
October 24, 2012
Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars
Robert Nicholson, Steve Lowes, Maria Cruz Caturla, et al.
Bioanalysis
|
February 27, 2016
9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks
Roger Hayes, Richard LeLacheur, Isabelle Dumont, et al.
Bioanalysis
|
March 29, 2012
Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC)
Mark Boterman, Mira Doig, Massimo Breda, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Bioanalysis
|
January 24, 2017
An ultra-sensitive LC-MS/MS method to determine midazolam levels in human plasma: development, validation and application to a clinical study
Mu Chen, Wenzhe Lu, Yang Lu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 13, 2019
Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine
Jeroen Roosendaal, Kai Wang, Hilde Rosing, et al.
Bioanalysis
|
November 24, 2012
Bioanalysis of drug in tissue: current status and challenges
Y-J Xue, Hong Gao, Qin C Ji, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 26, 2013
A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography-tandem mass spectrometry
Weisheng Lin, Mike-Qingtao Huang, Xiaohua Xue, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 14, 2014
Quantitative analyses of CTP-499 and five major metabolites by core-structure analysis
Xiaonan Tang, Gary Bridson, Jing Ke, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
May 1, 2012
Pilot and pivotal study to evaluate the bioequivalence of two paroxetine 40 mg tablet formulations in healthy Chinese subjects
Shengjun Zhang, Quancheng Kan, Jian Guo Wen, et al.
Bioanalysis
|
June 18, 2011
Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis
Steve Lowes, Jim Jersey, Ronald Shoup, et al.
Bioanalysis
|
October 24, 2012
Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars
Robert Nicholson, Steve Lowes, Maria Cruz Caturla, et al.
Bioanalysis
|
February 27, 2016
9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks
Roger Hayes, Richard LeLacheur, Isabelle Dumont, et al.
Bioanalysis
|
March 29, 2012
Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC)
Mark Boterman, Mira Doig, Massimo Breda, et al.
Page
of 4